BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 24, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Home
»
Topics
» BioWorld Science, Respiratory
BioWorld Science, Respiratory
RSS
Merck's asthma treatment receives first approvals
Sep. 4, 1997
Celltech prepares PDE IV inhibitors
Sep. 4, 1997
Sepracor's levalbuterol NDA accepted by FDA
Sep. 4, 1997
LT antagonist/antihistamine combination highly effective against EAR/LAR
Sep. 3, 1997
ET antagonists for asthma
Sep. 2, 1997
Anti-IgE antibody inhibits allergen-induced EAR
Sep. 2, 1997
North American clinical trials with LiquiVent to be reinitiated
Sep. 1, 1997
P&U cephem derivatives for inhibiting HLE
Aug. 29, 1997
FDA approves Hi-Tech's generic promethazine/codeine syrup
Aug. 28, 1997
Hoechst Marion Roussel reports new antiallergy agents
Aug. 25, 1997
Previous
1
2
…
646
647
648
649
650
651
652
653
654
…
694
695
Next